top of page
FMC-24-13 PNW Conference_Register_Banner_v1.png

​Earn AMA PRA Category 1 Credits™!

REGISTER NOW for the 2024 Pacific Northwest GI and Liver Update, taking place

Friday, October 4 – Saturday, October 5, 2024, at the Hyatt at Olive 8 in Seattle, WA. 
 
The conference will deliver focused educational updates highlighting clinically relevant advances in the management of patients with chronic liver disease (CLD) and gastrointestinal (GI) disorders. Renowned hepatologists and gastroenterologists will lead the development of educational content and serve as program faculty, reviewing state-of-the-art developments in GI disorders and CLD.

We hope to see you there!

Sincerely,​

Pacific Northwest GI & Liver Update Course Directors

Kris Kowdley, MD, AGAF, FAASLD, FACP, FACG
V. Raman Muthusamy, MD, MAS

Michael V. Chiorean, MD

Course Directors

COURSE DIRECTORS

chiorean.png

Michael V. Chiorean, MD

Swedish Seattle, WA

Kowdley.png

Kris Kowdley, MD, FACP, FACG, AGAF, FAASLD

Liver Institute Northwest Seattle, WA

Muthu.png

Raman Muthusamy, MD, MAS

University of Los Angeles Health Los Angeles, CA

AGENDA AT-A-GLANCE

Friday, October 4, 2024
11:30 AM                    Registration/Exhibit Hall
12:00 - 1:00 PM         Lunch Symposium (Accredited)
1:00 - 1:15 PM           Program Overview
1:15 - 2:50 PM           Hepatology

2:50 - 3:20 PM           Break/Exhibit Hall
3:20 - 5:00 PM           Endoscopy

5:30 - 6:15 PM           Industry-Sponsored Event
6:15 - 7:15 PM           Cocktail Hour

Saturday, October 5, 2024
7:30 - 8:45 AM                Registration/Breakfast/Exhibit Hall
7:45 - 8:30 AM                Industry-Sponsored Event
8:45 - 9:00 AM               Program Overview
9:00 - 10:35 AM             IBD

10:35 - 10:55 AM           Break/Exhibit Hall
10:55 AM - 12:30 PM    GI Hot Topics
1:00 - 1:45 PM                Industry-Sponsored Event
1:45 PM                           Adjournment

Jointly provided by the University of Cincinnati and Focus Medical Communications.
 

 

 

 


Supported by educational grants from Alnylam Pharmaceuticals, Inc., Gilead Sciences, Inc., Ipsen Biopharmaceuticals, Inc.,
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Orphalan Inc., and Salix Pharmaceuticals.

University of Cincinnati (UC) Logo.PNG

CONTACT
US

Email: pnwupdate@focusmeded.com
 
Pacific Northwest GI & Liver Update
C/O Focus Medical Communications, LLC

TELL
Us

Thanks for submitting!

© 2024 by Focus Medical Communications, LLC

bottom of page